Associations between cardiac fibrosis and permanent atrial fibrillation in advanced heart failure

Physiological Research

Volumn 62, Issue 3, 2013, Pages 247-255

  Aldhoon, B ^a   Kucera T ^b   Smorodinova N ^b   Martinek J ^b   Melenovsky V ^a   Kautzner, J ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atrial fibrillation; Atrial fibrosis; Connective tissue growth factor; Extracellular matrix; Heart failure; Transforming growth factor

Indexed keywords

COLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

AGING; ARTICLE; BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGING; ATRIAL FIBRILLATION; BLOOD PRESSURE; COLLAGEN; DIAGNOSIS, DIFFERENTIAL; ENDOMYOCARDIAL FIBROSIS; HEART ATRIA; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA;

EID: 84881532211     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ALDHOON B, MELENOVSKÝ V, PEICHL P, KAUTZNER J: New insights into mechanisms of atrial fibrillation. Physiol Res 59: 1-12, 2010.
2. ANNE W, WILLEMS R, ROSKAMS T, SERGEANT P, HERIJGERS P, HOLEMANS P, ECTOR H, HEIDBUCHEL H: Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 67: 655-666, 2005.
3. BEINART R, ABBARA S, BLUM A, FERENCIK M, HEIST K, RUSKIN J, MANSOUR M: Left atrial wall thickness variability measured by CT scans in patients undergoing pulmonary vein isolation. J Cardiovasc Electrophysiol 22: 1232-1236, 2011.
4. BURSTEIN B, NATTEL S: Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51: 802-809, 2008.
5. CIPOLLONE F, FAZIA M, MINCIONE G, IEZZI A, PINI B, CUCCURULLO C, UCCHINO S, SPIGONARDO F, DI NISIO M, CUCCURULLO F, MEZZETTI A, PORRECA E: Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke 35: 2253-2257, 2004.
6. CORONEL R, LANGERVELD J, BOERSMA LV, WEVER EF, BON L, VAN DESSEL PF, LINNENBANK AC, VAN GILST WH, ERNST SM, OPTHOF T, VAN HEMEL NM: Left atrial pressure reduction for mitral stenosis reverses left atrial direction-dependent conduction abnormalities. Cardiovasc Res 85: 711-718, 2010.
7. EVERETT THT, OLGIN JE: Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4: S24-S27, 2007.
8. GOETTE A, JUENEMANN G, PETERS B, KLEIN HU, ROESSNER A, HUTH C, ROCKEN C: Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res 54: 390-396, 2002.
9. GRAMLEY F, LORENZEN J, KOELLENSPERGER E, KETTERING K, WEISS C, MUNZEL T: Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway. Int J Cardiol 143: 405-413, 2010.
10. HALL B, JEEVANANTHAM V, SIMON R, FILIPPONE J, VOROBIOF G, DAUBERT J: Variation in left atrial transmural wall thickness at sites commonly targeted for ablation of atrial fibrillation. J Interv Card Electrophysiol 17: 127-132, 2006.
11. HANNA N, CARDIN S, LEUNG TK, NATTEL S: Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 63: 236-244, 2004.
12. IWANAGA Y, NISHI I, FURUICHI S, NOGUCHI T, SASE K, KIHARA Y, GOTO Y, NONOGI H: B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47: 742-748, 2006.
13. KANNEL WB, BENJAMIN EJ: Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin 27: 13-24, 2009.
14. KO WC, HONG CY, HOU SM, LIN CH, ONG ET, LEE CF, TSAI CT, LAI LP: Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. Circ J 75: 1592-1600, 2011.
15. KOITABASHI N, ARAI M, KOGURE S, NIWANO K, WATANABE A, AOKI Y, MAENO T, NISHIDA T, KUBOTA S, TAKIGAWA M, KURABAYASHI M: Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 49: 1120-1127, 2007.
16. LI D, SHINAGAWA K, PANG L, LEUNG TK, CARDIN S, WANG Z, NATTEL S: Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacinginduced congestive heart failure. Circulation 104: 2608-2614, 2001.
17. LIJNEN PJ, PETROV VV, FAGARD RH: Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71: 418-435, 2000.
18. MAISEL WH, STEVENSON LW: Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91: 2D-8D, 2003.
19. MUKHERJEE R, HERRON AR, LOWRY AS, STROUD RE, STROUD MR, WHARTON JM, IKONOMIDIS JS, CRUMBLEY AJ, SPINALE FG, GOLD MR: Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97: 532-537, 2006.
20. NAZIR SA, LAB MJ: Mechanoelectric feedback and atrial arrhythmias. Cardiovasc Res 32: 52-61, 1996.
21. PLATONOV PG, MITROFANOVA LB, ORSHANSKAYA V, HO SY: Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 58: 2225-2232, 2011.
22. POLYAKOVA V, HEIN S, KOSTIN S, ZIEGELHOEFFER T, SCHAPER J: Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 44: 1609-1618, 2004.
23. SANDERS P, MORTON JB, DAVIDSON NC, SPENCE SJ, VOHRA JK, SPARKS PB, KALMAN JM: Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108: 1461-1468, 2003.
24. SEKO Y, NISHIMURA H, TAKAHASHI N, ASHIDA T, NAGAI R: Serum levels of vascular endothelial growth factor and transforming growth factor-beta1 in patients with atrial fibrillation undergoing defibrillation therapy. Jpn Heart J 41: 27-32, 2000.
25. SONNYLAL S, SHI-WEN X, LEONI P, NAFF K, VAN PELT C S, NAKAMURA H, LEASK A, ABRAHAM D, BOU-GHARIOS G, DE CROMBRUGGHE B: Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 62: 1523-1532, 2010.
26. XU J, CUI G, ESMAILIAN F, PLUNKETT M, MARELLI D, ARDEHALI A, ODIM J, LAKS H, SEN L: Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109: 363-368, 2004.